(Q41500551)

1 October 2017

title

Structure-activity relationships of VP-16 analogues (English)

1 reference

1 October 2017

1 reference

B H Long

1

1 reference

1 October 2017

A M Casazza

series ordinal

2

1 reference

1 October 2017

publication date

1 January 1994

1 reference

Cancer Chemotherapy and Pharmacology

1 October 2017

published in

1 reference

1 October 2017

volume

34 Suppl

1 reference

1 October 2017

page(s)

S26-31

1 reference

Cell culture of human colon adenomas and carcinomas.

1 October 2017

cites work

1 reference

12 December 2020

Catalytic function of DNA topoisomerase II.

1 reference

12 December 2020

Topoisomerase-targeting antitumor drugs

1 reference

12 December 2020

Novel topologically knotted DNA from bacteriophage P4 capsids: studies with DNA topoisomerases

1 reference

12 December 2020

DNA topoisomerase II: a primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy

1 reference

12 December 2020

Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells

1 reference

12 December 2020

Intrinsic intermolecular DNA ligation activity of eukaryotic topoisomerase II. Potential roles in recombination

1 reference

12 December 2020

Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage

1 reference

12 December 2020

An in vivo human tumor xenograft model of etoposide resistance

1 reference

12 December 2020

From podophyllotoxin glucoside to etoposide

1 reference

12 December 2020

On the sequence similarity of the cohesive ends of coliphage P4, P2, and 186 deoxyribonucleic acid

1 reference

12 December 2020

4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action

1 reference

12 December 2020

Inhibition of growth of amethopterinsensitive and amethopterin-resistant pairs of lymphocytic neoplasms by dietary folic-acid deficiency in mice

1 reference

12 December 2020

Preparation and antitumor activity of 2''-O-, 3''-O- and 2'',3''-di-O-substituted derivatives of etoposide

1 reference

12 December 2020

Activity of a new glycosidic lignan derivative (VP 16-213) related to podophyllotoxin in experimental tumors.

1 reference

12 December 2020

Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines

1 reference

12 December 2020

Quantitative adaptation of the bacteriophage P4 DNA unknotting assay for use in the biochemical and pharmacological characterization of topoisomerase II

1 reference

12 December 2020

Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II

1 reference

12 December 2020

Qualitative and quantitative aspects of intercalator-induced DNA strand breaks

1 reference

12 December 2020

Preclinical antitumor activity of a soluble etoposide analog, BMY-40481-30

1 reference

12 December 2020

Characterization of VP-16-induced DNA damage in isolated nuclei from L1210 cells

1 reference

12 December 2020

DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity.

1 reference

12 December 2020

Heterogeneity of malignant cells from a human colonic carcinoma.

1 reference

12 December 2020

VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia

1 reference

12 December 2020

4'-demethylepipodophyllotoxin 9-(4,6-o-2-thenylidene-beta-D-glucopyranoside) (NSC-122819; VM-26) and 4'-demethylepipodophyllotoxin 9-(4.6-0-ethylidene-beta-D-glucopyranoside) (NSC-141540; VP-16-213) in childhood cancer: preliminary observations

1 reference

12 December 2020

Mechanisms of action of teniposide (VM-26) and comparison with etoposide (VP-16)

1 reference

12 December 2020

Synthesis and antimitotic activity of glycosidic lignan derivatives related to podophyllotoxin

1 reference

12 December 2020

Relationship between cytotoxicity and dna strand break-age produced by adriamycin and other intercalating agents

1 reference

12 December 2020

Inhibitors of topoisomerase II: structure-activity relationships and mechanism of action of podophyllin congeners.

1 reference

12 December 2020

Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26

1 reference

12 December 2020

Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia

1 reference

12 December 2020

Biochemical basis for the interactions of type I and type II topoisomerases with DNA.

1 reference

12 December 2020

Protein-associated DNA breaks in cells treated with adriamycin or ellipticine

1 reference

12 December 2020

The chemical and biological route from podophyllotoxin glucoside to etoposide: ninth Cain memorial Award lecture

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00684860

1 reference

Dimensions Publication ID

1 October 2017

1043997944

0 references

1 reference